Biennial Radiotherapy Physics Conference 2014
Total Page:16
File Type:pdf, Size:1020Kb
MPEC & BIENNIAL RADIOTHERAPY PHYSICS CONFERENCE 2014 31st August – 2nd September 2014 Scottish Exhibition & Conference Centre, Glasgow ABSTRACTS These papers are published with permission of the authors who have granted IPEM a non–exclusive right to publish, reproduce, distribute, display and store the abstract worldwide in all forms (including on the Institute’s website), formats and media now known or as developed in the future, including print, electronic and digital forms. Full copyright of the abstracts remains with the author. Copyright of this publication remains with IPEM. ISBN applied for (to follow). Institute of Physics & Engineering in Medicine Fairmount House 230 Tadcaster Road York YO24 1ES CONTENTS Sunday 31st August 2014 ........................................................................................................................ 3 Didactic Workshop on Research Governance I .................................................................................................. 3 Medical Device Safety – Managing Incidents ..................................................................................................... 4 Didactic Workshop on Research Governance II ................................................................................................. 7 Monday 1st September 2014 .................................................................................................................. 9 Professional Session I ....................................................................................................................................... 9 Biennial Radiotherapy Physics Conference – Diagnostic Radiology in RT .......................................................... 11 Trainee Session I ............................................................................................................................................ 15 Challenges in Medical Equipment Management .............................................................................................. 20 Magnetic Resonance Scientific Session ........................................................................................................... 23 Biennial Radiotherapy Physics Conference – Brachytherapy ............................................................................ 27 Trainee Session II ........................................................................................................................................... 29 Innovation in Physiological Measurement Services ......................................................................................... 32 General Imaging Scientific Session .................................................................................................................. 34 Woolmer lecture ............................................................................................................................................ 37 Professional Session II .................................................................................................................................... 37 Magnetic Resonance Imaging in Radiotherapy ................................................................................................ 38 Trainee Session III .......................................................................................................................................... 41 Innovation in Physiological Measurement Services ......................................................................................... 46 Diagnostic Radiology Session I – Doses in CT ................................................................................................... 50 Professional Session III ................................................................................................................................... 54 Biennial Radiotherapy Physics Conference – Quality Control in Radiotherapy .................................................. 55 New applications in rehabilitation and movement analysis ............................................................................. 59 Diagnostic Radiology Session II – Fluoroscopy and General Topics ................................................................... 64 Tuesday 2nd September 2014 ............................................................................................................... 68 IOP Plenary .................................................................................................................................................... 68 Update Scientific Session (Physical Agents, RPA) ............................................................................................. 68 Biennial Radiotherapy Physics Conference – Dosimetry .................................................................................. 69 Update Scientific Session (MPE & RWA) .......................................................................................................... 72 Biennial Radiotherapy Physics Conference – Planning I ................................................................................... 73 Author Workshop .......................................................................................................................................... 77 Update Scientific Session – RWA2000 ............................................................................................................. 77 AAG Scientific Session – Big Data I .................................................................................................................. 78 Biennial Radiotherapy Physics Conference – Planning III ................................................................................. 82 AAG Scientific Session – Big Data II ................................................................................................................. 86 POSTERS ............................................................................................................................................... 90 Sunday 31st August 2014 Sunday 31st August 2014, 14.00 – 15.15 Didactic Workshop on Research Governance I What is Research? Wyper D, Director of SINAPSE Email: [email protected] Website: www.sinapse.ac.uk In this presentation I shall outline the distinction between research and audit, and between service delivery research and biomedical research. I shall then discuss several issues that influence the quality of research: The benefits of having multi-disciplinary teams The need for multi-centre studies - and pitfalls in multi-centre studies How to attract adequate funding How to disseminate findings How to get research findings implemented. Finally I shall discuss some of the challenges facing NHS employees doing research. New Devices McCarthy J P, Clin Eng Consulting Ltd and Cardiff University School of Engineering email: [email protected] Developing a new device ‘in house’ for use in a research project is subject to different rules and regulations depending on the circumstances. REMEMBER a) Software can be a medical device in its own right even if running on a non-medical computer. b) Accessories (1) to a medical device e.g. a collimator to an LA, are treated as medical devices in their own right. 1. If the required device meets the definition of a ‘medical device’ (2) in the UK Medical Devices Regulations (2007) (based on the EU MDD, 1993 as amended), and if there is a commercially available CE marked device that meets the requirement, don’t reinvent the wheel. 2. If the purpose of the research project is to carry out a clinical investigation of a prototype medical device for which there is envisaged to be commercial potential, an application to MHRA for approval to continue must be made at least 60 days in advance. (3) MHRA will require the usual ethical and research governance assurances. 3. If the purpose of the device is to assist in carrying out the primary purpose of the research, and the device is not envisaged to fall into category 2 above, then the device probably does not fulfil the definition of a medical device and is not subject to the Regulations. 4. If the device does meet the ‘medical device’ definition, but is manufactured and used within the same corporate healthcare institution and there is no intent to commercialize the device, then MHRA guidance is that the Regulations do not apply since there is no ‘placing on the market’. (4) 5. If a CE marked medical device is to be used for a purpose not intended by the manufacturer - off- label use - then the risks and responsibilities fall on the research investigators and these must be made clear in the ethics application. (5) If commercial application is envisaged, then MHRA approval (point 2 above) will be required. 6. If a CE marked medical device is modified, either for routine clinical use or in the course of a research project, the institution authorizing the modification becomes the manufacturer. (5) 6(a) If the purpose of the research project is to investigate the clinical effectiveness of the modified device with a view to commercial application, then point 2 above applies. 6(b) If it is intended only to use the modified device within the same healthcare institution, then point 4 above applies. 7. Documented risk assessments, manufacturing devices using best practice, and meeting the MDD as far as possible, will meet professional obligations (CEng, CSci, HCPC). These steps will also reduce the chance of anything going wrong and give a strong defence in civil law if it does. Difficult situations